Business Law and Corporate Law

Subscribe
Business law and corporate law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics that involve business and corporate law produced by specialists working in this area every day.
Article
Do I Need A China NNN Agreement Or A China Manufacturing Agreement? Usually Both.
When manufacturing custom products in China, companies face critical decisions about legal protections at different stages of the supplier relationship. Understanding when to deploy an NNN Agreement versus a Manufacturing Agreement—and how to structure each for enforcement in Chinese courts—can mean the difference between protecting your intellectual property and losing control of your designs, molds, and market position.
Worldwide Commercial
HS
Harris Sliwoski
Article
Manus案的监管逻辑与AI企业跨境资本运作的合规路径
China's foreign investment security review office has issued its first-ever prohibition of an AI sector acquisition, blocking Meta's purchase of Manus and requiring transaction reversal. This landmark case establishes new compliance boundaries for cross-border capital operations involving strategic AI technologies, demonstrating that offshore restructuring cannot circumvent substantive regulatory oversight of technology transfers.
China Commercial
JT
Beijing Jincheng Tongda & Neal Law Firm
See more
Article
Do I Need A China NNN Agreement Or A China Manufacturing Agreement? Usually Both.
When manufacturing custom products in China, companies face critical decisions about legal protections at different stages of the supplier relationship. Understanding when to deploy an NNN Agreement versus a Manufacturing Agreement—and how to structure each for enforcement in Chinese courts—can mean the difference between protecting your intellectual property and losing control of your designs, molds, and market position.
Worldwide Commercial
HS
Harris Sliwoski
Article
Manus案的监管逻辑与AI企业跨境资本运作的合规路径
China's foreign investment security review office has issued its first-ever prohibition of an AI sector acquisition, blocking Meta's purchase of Manus and requiring transaction reversal. This landmark case establishes new compliance boundaries for cross-border capital operations involving strategic AI technologies, demonstrating that offshore restructuring cannot circumvent substantive regulatory oversight of technology transfers.
China Commercial
JT
Beijing Jincheng Tongda & Neal Law Firm
See more
Article
证券虚假陈述责任纠纷重大性认定中价格影响标准的类型化适用
2022年最高人民法院《关于审理证券市场虚假陈述侵权民事赔偿案件的若干规定》(法释〔2022〕2号,以下简称“《虚假陈述若干规定》”)第10条确立了价格影响标准(即《虚假陈述若干规定》第10条所称“交易价格或者交易量”是否受到影响的判断标准,本文简称价格影响标准),为被告提供了推
China Finance
AB
AnJie Broad Law Firm
See more
Article
Manus案的监管逻辑与AI企业跨境资本运作的合规路径
China's foreign investment security review office has issued its first-ever prohibition of an AI sector acquisition, blocking Meta's purchase of Manus and requiring transaction reversal. This landmark case establishes new compliance boundaries for cross-border capital operations involving strategic AI technologies, demonstrating that offshore restructuring cannot circumvent substantive regulatory oversight of technology transfers.
China Commercial
JT
Beijing Jincheng Tongda & Neal Law Firm
Article
2026上半年中国创新药跨境BD交易回顾与法律观察——交易标的扩展与合作模式演进
根据国家药监局经国家医保局官网转引的数据,2026年截至6月30日,我国创新药对外授权共81笔,交易总额约1,100亿美元,已达到2025年全年总额的80%;交易覆盖肿瘤、代谢、免疫、神经等十个治疗领域,主要被许可方来自20个国家和地区。[1]前述“交易总额”是各笔交易披露的最高潜在可量化金额之和,通
China Commercial
JT
Beijing Jincheng Tongda & Neal Law Firm
See more